Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Spike DNA co-immunization in rhesus macaques for control of Covid-19

Fast food for Bat guts: Banana Monoculture

Xenobiotic Metabolism Prediction by a novel methodology

Spike DNA co-immunization in rhesus macaques for control of Covid-19
  • BiotechToday
  • World

Spike DNA co-immunization in rhesus macaques for control of Covid-19

BioTech Today October 3, 2021October 3, 2021

Debarati Basu, Makaut WB

Vaccines derived from mRNA have greater versatility and efficacy for preventing Covid-19 infections. An effective alternative is DNA vaccines. It is used as it can induce humoral and cellular immune responses in animal models. They can also be utilized in human trials. The efficacy and immunogenicity of DNA-based vaccines were tested. The development of pike antigens occurs when the intramuscular injection is applied followed by the process of electroporation in rhesus macaques.

Various spike DNA vaccines procedure functions by antibody production that strongly neutralizes SARS-CoV-2 in vitro. It further induces vigorous T-cell responses. The antibodies then recognize and neutralize a group of various Spike variants. The spike variants mainly include Alpha, Delta, Epsilon, Eta, and A.23.1. It contains a small extent of Beta and Gamma spike variants also. A comparison was done between the regimen of DNA-based vaccines and co-immunization of Spike DNA regimen and protein located in the same anatomical site. Greater antibody responses were recorded for the latter one.

Control of SARS-CoV-2 in the intranasal channel is carried by all of the vaccine regimens. It also prevents the presence of viruses in the lower respiratory tract. Transient virus levels present in the nasal mucosa are inversely correlated with the vaccine-induced binding and neutralizing antibodies and also antibodies that induce cellular phagocytosis. One of the important properties of the Spike DNA+Protein co-immunization regimen is that it induces the greatest binding of antibodies. It also neutralizes antibodies. It is highly effective and can control Covid-19 in rhesus macaques.

Significance of the study:

Antibodies that are neutralized by anti-spike prove protection against Covid-19 infections in animal models as well as humans. It also provides high humoral immunity which acts as an important factor for protection. The study shows there are strong antibody and T cell responses by various Spike DNA-based vaccine procedures. It gives strong protection and control against Covid-19 infection. This is usually present in the rhesus macaque model. The study further provides information to compare vaccines that induce different humoral and cellular immune responses. It also helps in the development of long-lasting immunity against Covid-19 infections.

An alternative vaccine is obtained from alphavirus which is obtained from replicon RNA (repRNA). This vaccine provides robust anti-Spike humoral immune responses. This model is also being utilized clinically. One advantage of the DNA+Protein co-immunization procedure is that it provides maximum humoral and cellular immune responses. The vaccine is effective against Simian Immunodeficiency Virus (SIV) infections. It is also effective against the hybrid Simian Immunodeficiency Virus (SIV) model. This model is applied in rhesus macaques. The rhesus model used is of Indian origin.

Findings of the study:

Spike DNA and Spike DNA+Protein vaccination of rhesus macaques

The DNA-based vaccines induce strong Spike proteins that generate humoral and cellular responses. These responses also include cytotoxic T cell responses. It was also shown that the DNA+Protein co-immunization regimen induces the highest antibody levels in animals that were injected with them.

Effector function of Spike DNA vaccine-induced antibodies

It is shown the in vitro assays have DNA vaccines encoded by spike proteins. It induces Nab which controls Covid-19 infections. It is further shown that DNA+Protein immunization showed the highest antibody responses.

Conclusion:

The study showed two types of Covid-19 vaccines one was DNA-based only and the other was co-immunization of DNA and protein. The immunogenicity of DNA vaccines was measured by stabilized Spike proteins. The spike proteins differ by their presence or absence in the cleaving site and C-terminal of mice or rhesus model. One important factor of DNA+Proteins co-immunization procedures is that they provide effective virological control of the respiratory tract specifically of the upper regions.

DNA+Protein immunization showed the highest antibody responses when induced on the same site as obtained from studies on HIV/SIV DNA+Protein co-immunization. They also induce T cell responses and also generate strong anti-Spike antibody responses after a single vaccination. Protection from Covid-19 infections highly depends on the vaccine-generated immune responses in mucosal tissues. 

The study showed the difference in efficacy levels between 2or 3 Spike DNA vaccines. The data also showed after 2 immunizations there is a diminished efficacy during the initial control. It is due to the difference in the mucosal immune responses of the two regimens. The best protective response occurs after three-dose DNA+Protein co-immunization, it also provides rapid control of Covid-19 infections.

One of the disadvantages of this study is that there is a difference between vaccine procedures, animal facilities, and procedures to monitor immune responses, virus stocks, and so on. Challenges are faced while virus load measuring and so it is difficult to make a comparative report on NHP studies. Protective immunity is induced by SARS-CoV-2 Spike protein is also an immunogen. The study does not provide the data on the duration of the protective immunity which includes balance immune responses as well as cellular immune responses. But it is said that DNA vaccination may extend protective immunity.

Also read: Natural infection of Influenza produces effective antibodies against multiple strains

Reference:

  1. Rosati, M., Agarwal, M., Hu, X., Devasundaram, S., Stellas, D., Chowdhury, B., Bear, J., Burns, R., Donohue, D., Pessaint, L., Andersen, H., Lewis, M. G., Terpos, E., Dimopoulos, M. A., Wlodawer, A., Mullins, J. I., Venzon, D. J., Pavlakis, G. N., & Felber, B. K. (2021). Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques. PLOS Pathogens, 17(9), e1009701. https://doi.org/10.1371/journal.ppat.1009701
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged COVID19 DNA DNA Protein co-immunization DNA vaccines immune responses mRNA rhesus macaques SARS CoV 2 spike proteins T cell responses virology viruses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Xenobiotic Metabolism Prediction by a novel methodology

BioTech Today October 5, 2021

Sumedha B S, Bangalore University Xenobiotics: Xenobiotics are chemical substances that are foreign (extrinsic to the normal metabolism of an organism). These include- fragrances, drugs, pesticides, cosmetics, food additives, environmental pollutants, and industrial chemicals. It was found that humans are exposed to about 2 million xenobiotics in a lifetime. These chemicals gain access to the […]

Xenobiotic Metabolism

Related Post

  • BiotechToday
  • World

Nanoparticles to treat a common type of cancer- neuroblastoma

bioxone August 3, 2021August 2, 2021

Nandini Pharasi, Jaypee Institute of Information Technology What is neuroblastoma? Neuroblastoma is a condition in which malignant cells develop in the adrenal glands, neck, chest, or spinal cords neuroblasts (immature nerve tissue). A gene mutation (change) handed down from parent to kid can develop neuroblastoma. Neuroblastoma is responsible for 8–10% of all malignancies in children […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

BRAFi-addicted melanoma cells: proteomics and phosphoproteomics profiling

bioxone August 6, 2021August 5, 2021

Husna, Amity University Kolkata What is a BRAF inhibitor and what is its role? BRAF is a gene that is present on chromosome 7q34. It encodes a protein that has the ability to regulate the MAP kinase/ERKs-signaling pathway. These pathways have a crucial role in regulating cell division, differentiation, and the growth and proliferation of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Are viral vaccines safe for children with an autoimmune disorder?

bioxone February 16, 2021February 16, 2021

Husna, Amity University Kolkata An autoimmune disease is a condition in which the immune system mistakenly attacks the healthy cells of the body. Children with autoimmune diseases often require treatment with immunosuppressive drugs. So, in these patients, the efficacy and safety of vaccination, particularly the live attenuated vaccines remain a concern.  As the live attenuated […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy